《新股消息》三巽控股(06611.HK)今日起招股 入場費5,252.4元
內地房地產開發商三巽控股(06611.HK)公佈招股詳情,計劃發售1.65億股股份,當中10%在港公開發售,每股招股價介乎3.3至5.2元,每手1,000股,入場費爲5,252.4元。由今日(30日)起至7月12日公開招股,預計於7月19日上市。建銀國際爲獨家保薦人。
以招股價中位數4.25元計,公司預計集資淨額爲6.21億元,當中約60%將用作開發現有物業項目的建築成本;30%將用於土地收購,通過於安徽省及公司計劃進軍的安徽省周邊其他城市尋求及收購地塊或合適的併購機會,增加土地儲備;10%將用作一般營運資金用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.